[
  {
    "ts": null,
    "headline": "Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=2f821f6b26786cd9dee1b191276622e1f0c822c00aeb9a0567f5410801eb6556",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750177800,
      "headline": "Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors",
      "id": 135406395,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=2f821f6b26786cd9dee1b191276622e1f0c822c00aeb9a0567f5410801eb6556"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Announces Endosafe Cartridge Recycling Program, Strengthening Sustainability Commitment",
    "summary": "WILMINGTON - Charles River Laboratories International, Inc. today announced a recycling program, developed in partnership with international recycling leader TerraCycle, to give new life to...",
    "url": "https://finnhub.io/api/news?id=fa0387429919f360cb05f35f5266dfca339cd0f363286f72f21cfb5118cd3f04",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750143880,
      "headline": "Charles River Announces Endosafe Cartridge Recycling Program, Strengthening Sustainability Commitment",
      "id": 135325473,
      "image": "",
      "related": "CRL",
      "source": "Finnhub",
      "summary": "WILMINGTON - Charles River Laboratories International, Inc. today announced a recycling program, developed in partnership with international recycling leader TerraCycle, to give new life to...",
      "url": "https://finnhub.io/api/news?id=fa0387429919f360cb05f35f5266dfca339cd0f363286f72f21cfb5118cd3f04"
    }
  },
  {
    "ts": null,
    "headline": "3 Unpopular Stocks in Hot Water",
    "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
    "url": "https://finnhub.io/api/news?id=eda2cfd90207add0af44e4d4042581ebee8b89501ae6744ce2c64c9ad0bc1b20",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750134760,
      "headline": "3 Unpopular Stocks in Hot Water",
      "id": 135325912,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.",
      "url": "https://finnhub.io/api/news?id=eda2cfd90207add0af44e4d4042581ebee8b89501ae6744ce2c64c9ad0bc1b20"
    }
  },
  {
    "ts": null,
    "headline": "Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE)",
    "summary": "As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Fortrea (NASDAQ:FTRE) and its peers.",
    "url": "https://finnhub.io/api/news?id=a001f5d4467394f9a4b80a12af3d37e3da69c826096b1692a079563d7400594e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750131514,
      "headline": "Drug Development Inputs & Services Stocks Q1 Recap: Benchmarking Fortrea (NASDAQ:FTRE)",
      "id": 135327358,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Fortrea (NASDAQ:FTRE) and its peers.",
      "url": "https://finnhub.io/api/news?id=a001f5d4467394f9a4b80a12af3d37e3da69c826096b1692a079563d7400594e"
    }
  },
  {
    "ts": null,
    "headline": "Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)",
    "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest of the drug development inputs & services stocks fared in Q1.",
    "url": "https://finnhub.io/api/news?id=4f2a260ebd81381797a9119cb6109d70d0b10896a9d9d17b9ddad0a2160cfcf8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750131269,
      "headline": "Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV)",
      "id": 135327359,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest of the drug development inputs & services stocks fared in Q1.",
      "url": "https://finnhub.io/api/news?id=4f2a260ebd81381797a9119cb6109d70d0b10896a9d9d17b9ddad0a2160cfcf8"
    }
  }
]